Related Experiment Video
Updated: Apr 25, 2026

Automated Measurement of Pulmonary Emphysema and Small Airway Remodeling in Cigarette Smoke-exposed Mice
Published on: January 16, 2015
The relationship between atherosclerosis and pulmonary emphysema
Vascular and alveolar macrophages are key players in atherosclerosis and pulmonary emphysema. Oxidative stress from factors like cigarette smoke drives foam cell formation and inflammation in these diseases.
Area of Science:
- Cardiovascular Research
- Pulmonary Medicine
- Cellular Biology
Background:
- The exact causes of atherosclerosis and pulmonary emphysema remain unclear.
- Foam cell formation is central to the pathogenesis of these conditions.
Purpose of the Study:
- To elucidate the role of macrophages and oxidative stress in the development of atherosclerosis and pulmonary emphysema.
Main Methods:
- Investigated the process of foam cell formation involving lipoprotein modification and scavenger receptor-mediated uptake by macrophages.
- Examined the impact of local cytokine secretion and reactive oxygen species (ROS) generation.
- Considered the influence of cigarette smoke as a source of oxidants.
Main Results:
- Foam cell formation is mediated by macrophage internalization of modified lipoproteins.
- Oxidative stress exacerbates inflammation through ROS production, further lipoprotein modification, and cytokine release.
- Oxidants impair antiprotease function and damage matrix proteins, hindering tissue repair.
Conclusions:
- Vascular and alveolar macrophages play a critical role in the pathogenesis of atherosclerosis and pulmonary emphysema.
- Understanding macrophage function is crucial for developing therapeutic strategies.
Related Concept Videos
Chronic Obstructive Pulmonary Disease II: Emphysema
Chronic Obstructive Pulmonary Disease-II: Pathophysiology
Chronic Inflammation
Chronic Obstructive Pulmonary Disease I: Introduction
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features
Atherosclerosis I: Introduction
Chronic Obstructive Pulmonary Disease IV: Clinical Manifestations

